ICON Other Non-Cash Items 2010-2025 | ICLR
ICON annual/quarterly other non-cash items history and growth rate from 2010 to 2025. Other non-cash items can be defined as miscellaneous non-cash adjustments to Net income.
- ICON other non-cash items for the quarter ending March 31, 2025 were $0.025B, a 922.33% decline year-over-year.
- ICON other non-cash items for the twelve months ending March 31, 2025 were $0.201B, a 146.72% increase year-over-year.
- ICON annual other non-cash items for 2024 were $0.063B, a 15.92% decline from 2023.
- ICON annual other non-cash items for 2023 were $0.075B, a 94.11% increase from 2022.
- ICON annual other non-cash items for 2022 were $0.039B, a 82.87% decline from 2021.
| ICON Annual Other Non-Cash Items (Millions of US $) |
|
|---|---|
| 2024 | $63 |
| 2023 | $75 |
| 2022 | $39 |
| 2021 | $226 |
| 2020 | $60 |
| 2019 | $28 |
| 2018 | $31 |
| 2017 | $40 |
| 2016 | $41 |
| 2015 | $36 |
| 2014 | $14 |
| 2013 | $4 |
| 2012 | $1 |
| 2011 | $N/A |
| 2010 | $N/A |
| 2009 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.879B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.784B | 27.53 |
| Elevance Health (ELV) | United States | $87.260B | 11.26 |
| CVS Health (CVS) | United States | $83.934B | 10.43 |
| Cencora (COR) | United States | $57.186B | 19.90 |
| Natera (NTRA) | United States | $22.441B | 0.00 |
| DiDi Global (DIDIY) | China | $22.121B | 23.50 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.895B | 0.00 |
| Solventum (SOLV) | United States | $12.853B | 13.61 |
| CochLear (CHEOY) | Australia | $11.671B | 0.00 |
| Revvity (RVTY) | United States | $11.280B | 19.41 |
| Doximity (DOCS) | United States | $10.697B | 49.52 |
| Viatris (VTRS) | United States | $10.669B | 3.67 |
| Avantor (AVTR) | United States | $9.227B | 13.41 |
| HealthEquity (HQY) | United States | $8.993B | 39.39 |
| Medpace Holdings (MEDP) | United States | $8.737B | 23.21 |
| Sonic Healthcare (SKHHY) | Australia | $8.503B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.460B | 14.62 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.400B | 25.92 |
| BrightSpring Health Services (BTSG) | United States | $3.797B | 34.84 |
| Sotera Health (SHC) | United States | $3.335B | 18.95 |
| Alignment Healthcare (ALHC) | United States | $2.983B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.961B | 38.50 |
| Concentras Parent (CON) | United States | $2.793B | 16.14 |
| Organon (OGN) | United States | $2.618B | 2.78 |
| Ardent Health (ARDT) | United States | $1.938B | 8.26 |
| GeneDx Holdings (WGS) | United States | $1.894B | 72.93 |
| Premier (PINC) | United States | $1.855B | 14.08 |
| Progyny (PGNY) | United States | $1.847B | 40.66 |
| PACS (PACS) | United States | $1.614B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.600B | 32.00 |
| Teladoc Health (TDOC) | United States | $1.258B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.224B | 9.31 |
| Establishment Labs Holdings (ESTA) | $1.073B | 0.00 | |
| CareDx (CDNA) | United States | $1.048B | 16.37 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.907B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.828B | 7.75 |
| QDM (QDMI) | Hong Kong, SAR China | $0.763B | 0.00 |
| Nutex Health (NUTX) | United States | $0.694B | 10.51 |
| Embecta (EMBC) | United States | $0.587B | 3.95 |
| LifeMD (LFMD) | United States | $0.577B | 0.00 |
| Enhabit (EHAB) | United States | $0.505B | 41.54 |
| InnovAge Holding (INNV) | United States | $0.498B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.469B | 10.57 |
| Sonida Senior Living (SNDA) | United States | $0.467B | 0.00 |
| SBC Medicals (SBC) | United States | $0.464B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.423B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.257B | 0.00 |
| Oncology Institute (TOI) | United States | $0.236B | 0.00 |
| Beauty Health (SKIN) | United States | $0.197B | 0.00 |
| DocGo (DCGO) | United States | $0.154B | 25.17 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.111B | 0.00 |
| KindlyMD (NAKA) | United States | $0.102B | 0.00 |
| So-Young (SY) | China | $0.095B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.087B | 0.00 |
| OncoCyte (OCX) | United States | $0.077B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.067B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| ModivCare (MODV) | United States | $0.048B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |